Dougherty & Co Downgrades Dolby Laboratories (DLB) to Neutral

Go back to Dougherty & Co Downgrades Dolby Laboratories (DLB) to Neutral

Dolby Laboratories Inc. (DLB) Tops Q3 EPS by 17c; Guides FY13 Revs Below

July 25, 2013 4:53 PM EDT

Dolby Laboratories Inc. (NYSE: DLB) reported Q3 EPS of $0.47, $0.17 better than the analyst estimate of $0.30. Revenue for the quarter came in at $207.1 million versus the consensus estimate of $208.8 million.

Dolby Laboratories Inc. sees Q4 2013 EPS of $0.30-$0.36, versus the consensus of $0.43. Dolby... More